ÐÇ¿Õ´«Ã½

Journal Article

1. Kirwa K, Gassett AJ, Sack C, Paulin LM, Pirozzi CS, Barr RG, Woodruff PG, Han M, Wilgus ML, Barjaktarevic I, Peters S, Hansel NN, Kaufman JD (2024). Estimating ambient air pollutant concentrations outside and inside homes in the Subpopulations and Intermediate outcomes in COPD air pollution (SPIROMICS air) cohort. Environ Res, 259, 119512. ()
2. Baddour NA, Paulin LM, Gassett AJ, Woo H, Hoffman EA, Newell JD Jr, Woodruff PG, Pirozzi CS, Barjaktarevic I, Barr RG, ONeal W, Han MK, Martinez FJ, Peters SP, Hastie AT, Hansel NN, Ortega VE, Kaufman JD, Sack CS (2025). Air Pollution Exposure and Interstitial Lung Features in SPIROMICS Participants with Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc, 21(9), 1251-1260. ()
3. Baddour NA, Paulin LM, Gassett AJ, Woo H, Hoffman EA, Newell JD Jr, Woodruff PG, Pirozzi CS, Barjaktarevic I, Barr RG, ONeal W, Han MK, Martinez FJ, Peters SP, Hastie AT, Hansel NN, Ortega VE, Kaufman JD, Sack CS (2024). Air Pollution Exposure and Interstitial Lung Features in SPIROMICS Participants with COPD. Ann Am Thorac Soc, 21(9), 1251-1260. ()
4. Hansel NN, Woo H, Koehler K, Gassett A, Paulin LM, Alexis NE, Putcha N, Lorizio W, Fawzy A, Belz D, Sack C, Barr RG, Martinez FJ, Han MK, Woodruff P, Pirozzi C, Paine R 3rd, Barjaktarevic I, Cooper CB, Ortega V, Zusman M, Kaufman JD (2024). Indoor Pollution and Lung Function Decline in Current and Former Smokers: SPIROMICS AIR. Am J Respir Crit Care Med, 208(10), 1042-1051. ()
5. Rous JS, Lees PSJ, Koehler K, Buckley JP, Quirs-Alcal L, Han MK, Hoffman EA, Labaki W, Barr RG, Peters SP, Paine R 3rd, Pirozzi C, Cooper CB, Dransfield MT, Comellas AP, Kanner RE, Drummond MB, Putcha N, Hansel NN, Paulin LM (2023). Association of occupational exposures and chronic obstructive pulmonary disease morbidity. J Occup Environ Med. ()
6. Tejwani V, Woo H, Liu C, Tillery AK, Gassett AJ, Kanner RE, Hoffman EA, Martinez FJ, Woodruff PG, Barr RG, Fawzy A, Koehler K, Curtis JL, Freeman CM, Cooper CB, Comellas AP, Pirozzi C, Paine R, Tashkin D, Krishnan JA, Sack C, Putcha N, Paulin LM, Zusman M, Kaufman JD, Alexis NE, Hansel NN (2022). Black carbon content in airway macrophages is associated with increased severe exacerbations and worse COPD morbidity in SPIROMICS. Respir Res, 23(1), 310. ()
7. Ronish BE, Couper DJ, Barjaktarevic IZ, Cooper CB, Kanner RE, Pirozzi CS, Kim V, Wells JM, Han MK, Woodruff PG, Ortega VE, Peters SP, Hoffman EA, Buhr RG, Dolezal BA, Tashkin DP, Liou TG, Bateman LA, Schroeder JD, Martinez FJ, Barr RG, Hansel NN, Comellas AP, Rennard SI, Arjomandi M, Paine Iii R (2022). Forced Expiratory Flow at 25%-75% Links COPD Physiology to Emphysema and Disease Severity in the SPIROMICS Cohort. Chronic Obstr Pulm Dis, 9(2), 111-121. ()
8. Belz DC, Woo H, Putcha N, Paulin LM, Koehler K, Fawzy A, Alexis NE, Barr RG, Comellas AP, Cooper CB, Couper D, Dransfield M, Gassett AJ, Han M, Hoffman EA, Kanner RE, Krishnan JA, Martinez FJ, Paine R 3rd, Peng RD, Peters S, Pirozzi CS, Woodruff PG, Kaufman JD, Hansel NN, SPIROMICS Investigators (2022). Ambient ozone effects on respiratory outcomes among smokers modified by neighborhood poverty: An analysis of SPIROMICS AIR. Sci Total Environ, 829, 154694. ()
9. Johnson SA, Mendoza DL, Zhang Y, Pirozzi CS (2021). Effects of Short-Term Air Pollution Exposure on Venous Thromboembolism: A Case-Crossover Study. Ann Am Thorac Soc, 18(12), 1988-1996. ()
10. Laumbach RJ, Cromar KR, Adamkiewicz G, Carlsten C, Charpin D, Chan WR, de Nazelle A, Forastiere F, Goldstein J, Gumy S, Hallman WK, Jerrett M, Kipen HM, Pirozzi CS, Polivka BJ, Radbel J, Shaffer RE, Sin DD, Viegi G (2021). Personal Interventions for Reducing Exposure and Risk for Outdoor Air Pollution: An Official American Thoracic Society Workshop Report. Ann Am Thorac Soc, 18(9), 1435-1443. ()
11. Aberegg SK, Cirulis MM, Maddock SD, Freeman A, Keenan LM, Pirozzi CS, Raman SM, Schroeder J, Mann H, Callahan SJ (2020). Clinical, Bronchoscopic, and Imaging Findings of e-Cigarette, or Vaping, Product Use-Associated Lung Injury Among Patients Treated at an Academic Medical Center. JAMA Netw Open, 3(11), e2019176. ()
12. Mendoza DL, Pirozzi CS, Crosman ET, Liou TG, Zhang Y, Cleeves JJ, Bannister SC, Anderegg WRL, Robert P 3rd (2020). Impact of low-level fine particulate matter and ozone exposure on absences in K-12 students and economic consequences. Environ Res Lett, 15(11). ()
13. Ortega VE, Li X, ONeal WK, Lackey L, Ampleford E, Hawkins GA, Grayeski PJ, Laederach A, Barjaktarevic I, Barr RG, Cooper C, Couper D, Han MK, Kanner RE, Kleerup EC, Martinez FJ, Paine Iii R, Peters SPPirozzi C, Rennard SI, Woodruff PG, Hoffman EA, Meyers DA, Bleecker ER NHLBI Subpopulations and Intermediate Outcomes Measures in COPD Study SPIROMICS (2020). The Effects of Rare SERPINA1 Variants on Lung Function and Emphysema in SPIROMICS. Am J Respir Crit Care Med, 201(5), 540-554.
14. Maddock SD, Cirulis MM, Callahan SJ, Keenan LM, Pirozzi CS, Raman SM, Aberegg SK (2019). Pulmonary Lipid-Laden Macrophages and Vaping.  . N Engl J Med, 381(15), 1488-1489.
15. Pirozzi CS, Jones BE, VanDerslice JA, Zhang Y, Paine R 3rd, Dean NC (April 1 2018). Short-Term Air Pollution and Incident Pneumonia: A Case-Crossover Study. Ann Am Thorac Soc, 15(4), 449-459.
16. Hansel NN, Paulin LM, Gassett AJ, Peng RD, Alexis N, Fan VS, Bleecker E, Bowler R, Comellas AP, Dransfield M, Han MK, Kim V, Krishnan JA, Pirozzi C, Cooper CB, Martinez F, Woodruff PG, Breysse PJ, Barr RG, Kaufman JD (2017). Design of the Subpopulations and Intermediate Outcome Measures in COPD (SPIROMICS) AIR Study. BMJ Open Respir Res, 4(1), e000186. ()
17. Martinez CH, Diaz AA, Meldrum C, Curtis JL, Cooper CB, Pirozzi C, Kanner RE, Paine R 3rd, Woodruff PG, Bleecker ER, Hansel NN, Barr RG, Marchetti N, Criner GJ, Kazerooni EA, Hoffman EA, Ross BD, Galban CJ, Cigolle CT, Martinez FJ, Han MK, SPIROMICS Investigators (2016). Age and Small Airway Imaging Abnormalities in Subjects with and without Airflow Obstruction in SPIROMICS. Am J Respir Crit Care Med, 195(4), 464-472. ()

Letter

1. Maddock SD, Cirulis MM, Callahan SJ, Keenan LM, Pirozzi CS, Raman SM, Aberegg SK (2019). Pulmonary Lipid-Laden Macrophages and Vaping. [Letter to the editor]. N Engl J Med, 381(15), 1488-1489. ()

Other

1. Zusman M, Gassett AJ, Kirwa K, Barr RG, Cooper CB, Han MK, Kanner RE, Koehler K, Ortega VE, Paine Rd R, Paulin L, Pirozzi C, Rule A, Hansel NN, Kaufman JD (2020). Modeling residential indoor concentrations of PM2.5 , NO2 , NOx , and secondhand smoke in the Subpopulations and Intermediate Outcome Measures in COPD (SPIROMICS) Air study. Indoor Air (31(3), pp. 702-716). England. ()
2. Burkes RM, Ceppe AS, Doerschuk CM, Couper D, Hoffman EA, Comellas AP, Barr RG, Krishnan JA, Cooper C, Labaki WW, Ortega VE, Wells JM, Criner GJ, Woodruff PG, Bowler RP, Pirozzi CS, Hansel NN, Wise RA, Brown TT, Drummond MB, SPIROMICS Investigators (2020). Associations Among 25-Hydroxyvitamin D Levels, Lung Function, and Exacerbation Outcomes in COPD: An Analysis of the SPIROMICS Cohort. Chest (157(4), pp. 856-865). United States. ()
3. Ortega VE, Li X, ONeal WK, Lackey L, Ampleford E, Hawkins GA, Grayeski PJ, Laederach A, Barjaktarevic I, Barr RG, Cooper C, Couper D, Han MK, Kanner RE, Kleerup EC, Martinez FJ, Paine R 3rd, Peters SP, Pirozzi C, Rennard SI, Woodruff PG, Hoffman EA, Meyers DA, Bleecker ER, NHLBI Subpopulations and Intermediate Outcomes Measures in COPD Study SPIROMICS (2019). The Effects of Rare SERPINA1 Variants on Lung Function and Emphysema in SPIROMICS. Am J Respir Crit Care Med (201(5), pp. 540-554). United States. ()
4. Paulin LM, Gassett AJ, Alexis NE, Kirwa K, Kanner RE, Peters S, Krishnan JA, Paine R 3rd, Dransfield M, Woodruff PG, Cooper CB, Barr RG, Comellas AP, Pirozzi CS, Han M, Hoffman EA, Martinez FJ, Woo H, Peng RD, Fawzy A, Putcha N, Breysse PN, Kaufman JD, Hansel NN, for SPIROMICS investigators (2019). Association of Long-term Ambient Ozone Exposure With Respiratory Morbidity in Smokers. JAMA Intern Med (180(1), pp. 106-115). United States. ()
5. Paulin LM, Smith BM, Koch A, Han M, Hoffman EA, Martinez C, Ejike C, Blanc PD, Rous J, Barr RG, Peters SP, Paine R 3rd, Pirozzi C, Cooper CB, Dransfield MT, Comellas AP, Kanner RE, Drummond MB, Putcha N, Hansel NN (2018). Occupational Exposures and Computed Tomographic Imaging Characteristics in the SPIROMICS Cohort. Ann Am Thorac Soc (15(12), pp. 1411-1419). United States. ()
6. Pirozzi CS, Gu T, Quibrera PM, Carretta EE, Han MK, Murray S, Cooper CB, Tashkin DP, Kleerup EC, Barjaktarevic I, Hoffman EA, Martinez CH, Christenson SA, Hansel NN, Graham Barr R, Bleecker ER, Ortega VE, Martinez FJ, Kanner RE, Paine R 3rd, NHLBI SubPopulations and InteRmediate Outcome Measures In COPD Study SPIROMICS (2018). Heterogeneous burden of lung disease in smokers with borderline airflow obstruction. Respir Res (19(1), p. 223). England. ()
7. Pirozzi CS, Mendoza DL, Xu Y, Zhang Y, Scholand MB, Baughman RP (2018). Short-Term Particulate Air Pollution Exposure is Associated with Increased Severity of Respiratory and Quality of Life Symptoms in Patients with Fibrotic Sarcoidosis. Int J Environ Res Public ÐÇ¿Õ´«Ã½ (15(6)). Switzerland. ()
8. Pirozzi CS, Jones BE, VanDerslice JA, Zhang Y, Paine R 3rd, Dean NC (2017). Short-Term Air Pollution and Incident Pneumonia. A Case-Crossover Study. Ann Am Thorac Soc (15(4), pp. 449-459). United States. ()

News

• La mala calidad del aire y su impacto en la salud
• Poor Air Quality and the Impact on Your ÐÇ¿Õ´«Ã½
• 10 Tips for Isolation If You Have COVID-19
• Hawaiian Teriyaki Chicken Skewers